NCT07044271View on ClinicalTrials.gov

A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy Participants

PHASE1RecruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

July 11, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions

Healthy

Interventions

DRUG

Olomorasib

Single dose

Trial Locations (2)

78209

RECRUITING

ICON Early Phase Services, San Antonio

84124

RECRUITING

ICON, Salt Lake City

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY